Osteoarthritis - Pipeline Review, H1 2017

ReportsWeb.com has announced the addition of the “Osteoarthritis - Pipeline Review, H1 2017” this report provides an overview of the Osteoarthritis (Immunology) pipeline landscape.

Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries and obesity. Treatment includes surgery, medications like non-steroidal anti-inflammatory drugs (NSAIDs) and exercise.

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Osteoarthritis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Osteoarthritis (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Osteoarthritis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 7, 21, 14, 46 and 14 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 5 and 5 molecules, respectively.

Osteoarthritis (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

For more information about this report at http://www.reportsweb.com/osteoarthritis-pipeline-review-h1-2017

Report Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Osteoarthritis (Immunology).
- The pipeline guide reviews pipeline therapeutics for Osteoarthritis (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Osteoarthritis (Immunology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Osteoarthritis (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Osteoarthritis (Immunology)

Request a sample copy at http://www.reportsweb.com/inquiry&RW0001689443/sample

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Osteoarthritis (Immunology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Osteoarthritis (Immunology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Key Company profiles

A. Menarini Industrie Farmaceutiche Riunite Srl
AbbVie Inc
Abiogen Pharma SpA
Ablynx NV
Achelios Therapeutics Inc
Addex Therapeutics Ltd
Amgen Inc
Amura Holdings Ltd
Arcarios BV
Asahi Kasei Pharma Corp
Asklepios BioPharmaceutical Inc
Astellas Pharma Inc
Biopharm GmbH
Bone Therapeutics SA
Can-Fite BioPharma Ltd
Cardax Inc
Cellular Biomedicine Group Inc
Cipla Ltd
Corestem Inc
Dong-A Socio Holdings Co Ltd
Evgen Pharma Plc
F. Hoffmann-La Roche Ltd
Galapagos NV
Gemphire Therapeutics Inc
GeneFrontier Corp
Genequine Biotherapeutics GmbH
GlaxoSmithKline Plc
HSRx Group
InKemia IUCT Group SA
International Stem Cell Corp
Jeil Pharmaceutical Co Ltd
Jenrin Discovery Inc
K-Stemcell Co Ltd
Kang Stem Biotech Co Ltd
Levolta Pharmaceuticals Inc
LG Chem, Ltd.
Marina Biotech Inc
Medivir AB
Merck KGaA
Mesoblast Ltd
Mor Research Application Ltd
NicOx SA
Nordic Bioscience A/S
Novartis AG
NovelMed Therapeutics Inc
Omeros Corp
Ono Pharmaceutical Co Ltd
OrthoCyte Corp
Osteologix Holdings Plc
Pfizer Inc
Pharmalink AB
Philogen SpA
PhytoHealth Corp
PLx Pharma Inc
ProteoThera Inc
Regeneus Ltd
Regulaxis SAS
Rottapharm Biotech Srl
Samumed LLC
Seikagaku Corp
Stelis Biopharma Pvt Ltd
Takeda Pharmaceutical Company Ltd
TissueGene Inc
Yooyoung Pharmaceutical Co Ltd
Yuhan Corp
Yungjin Pharm Co Ltd
Zimmer Biomet Holdings Inc

Ask for Discount at http://www.reportsweb.com/inquiry&RW0001689443/discount

List of Tables

Number of Products under Development for Osteoarthritis, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Products under Development by Companies, H1 2017 (Contd..2), H1 2017
Products under Development by Companies, H1 2017 (Contd..3), H1 2017
Products under Development by Companies, H1 2017 (Contd..4), H1 2017
Products under Development by Companies, H1 2017 (Contd..5), H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Target, H1 2017 (Contd..1), H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1), H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Osteoarthritis - Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H1 2017
Osteoarthritis - Pipeline by AbbVie Inc, H1 2017
Osteoarthritis - Pipeline by Abiogen Pharma SpA, H1 2017
Osteoarthritis - Pipeline by Ablynx NV, H1 2017
Osteoarthritis - Pipeline by Achelios Therapeutics Inc, H1 2017
Osteoarthritis - Pipeline by Addex Therapeutics Ltd, H1 2017
Osteoarthritis - Pipeline by Amgen Inc, H1 2017
Osteoarthritis - Pipeline by Amura Holdings Ltd, H1 2017
Osteoarthritis - Pipeline by Arcarios BV, H1 2017
Osteoarthritis - Pipeline by Asahi Kasei Pharma Corp, H1 2017
Osteoarthritis - Pipeline by Asklepios BioPharmaceutical Inc, H1 2017
Osteoarthritis - Pipeline by Astellas Pharma Inc, H1 2017
Osteoarthritis - Pipeline by Biopharm GmbH, H1 2017
Osteoarthritis - Pipeline by Bone Therapeutics SA, H1 2017
Osteoarthritis - Pipeline by Can-Fite BioPharma Ltd, H1 2017
Osteoarthritis - Pipeline by Cardax Inc, H1 2017
Osteoarthritis - Pipeline by Cellular Biomedicine Group Inc, H1 2017
Osteoarthritis - Pipeline by Cipla Ltd, H1 2017
Osteoarthritis - Pipeline by Corestem Inc, H1 2017
Osteoarthritis - Pipeline by Dong-A Socio Holdings Co Ltd, H1 2017
Osteoarthritis - Pipeline by Evgen Pharma Plc, H1 2017
Osteoarthritis - Pipeline by F. Hoffmann-La Roche Ltd, H1 2017
Osteoarthritis - Pipeline by Galapagos NV, H1 2017
Osteoarthritis - Pipeline by Gemphire Therapeutics Inc, H1 2017
Osteoarthritis - Pipeline by GeneFrontier Corp, H1 2017
Osteoarthritis - Pipeline by Genequine Biotherapeutics GmbH, H1 2017
Osteoarthritis - Pipeline by GlaxoSmithKline Plc, H1 2017
Osteoarthritis - Pipeline by HSRx Group, H1 2017
Osteoarthritis - Pipeline by InKemia IUCT Group SA, H1 2017
Osteoarthritis - Pipeline by International Stem Cell Corp, H1 2017
Osteoarthritis - Pipeline by Jeil Pharmaceutical Co Ltd, H1 2017
Osteoarthritis - Pipeline by Jenrin Discovery Inc, H1 2017
Osteoarthritis - Pipeline by K-Stemcell Co Ltd, H1 2017
Osteoarthritis - Pipeline by Kang Stem Biotech Co Ltd, H1 2017
Osteoarthritis - Pipeline by Levolta Pharmaceuticals Inc, H1 2017
Osteoarthritis - Pipeline by LG Chem, Ltd., H1 2017
Osteoarthritis - Pipeline by Marina Biotech Inc, H1 2017
Osteoarthritis - Pipeline by Medivir AB, H1 2017
Osteoarthritis - Pipeline by Merck KGaA, H1 2017
Osteoarthritis - Pipeline by Mesoblast Ltd, H1 2017
Osteoarthritis - Pipeline by Mor Research Application Ltd, H1 2017
Osteoarthritis - Pipeline by NicOx SA, H1 2017
Osteoarthritis - Pipeline by Nordic Bioscience A/S, H1 2017
Osteoarthritis - Pipeline by Novartis AG, H1 2017
Osteoarthritis - Pipeline by NovelMed Therapeutics Inc, H1 2017
Osteoarthritis - Pipeline by Omeros Corp, H1 2017
Osteoarthritis - Pipeline by Ono Pharmaceutical Co Ltd, H1 2017
Osteoarthritis - Pipeline by OrthoCyte Corp, H1 2017
Osteoarthritis - Pipeline by Osteologix Holdings Plc, H1 2017
Osteoarthritis - Pipeline by Pfizer Inc, H1 2017
Osteoarthritis - Pipeline by Pharmalink AB, H1 2017
Osteoarthritis - Pipeline by Philogen SpA, H1 2017
Osteoarthritis - Pipeline by PhytoHealth Corp, H1 2017
Osteoarthritis - Pipeline by PLx Pharma Inc, H1 2017
Osteoarthritis - Pipeline by ProteoThera Inc, H1 2017
Osteoarthritis - Pipeline by Regeneus Ltd, H1 2017
Osteoarthritis - Pipeline by Regulaxis SAS, H1 2017
Osteoarthritis - Pipeline by Rottapharm Biotech Srl, H1 2017
Osteoarthritis - Pipeline by Samumed LLC, H1 2017
Osteoarthritis - Pipeline by Seikagaku Corp, H1 2017
Osteoarthritis - Pipeline by Stelis Biopharma Pvt Ltd, H1 2017
Osteoarthritis - Pipeline by Takeda Pharmaceutical Company Ltd, H1 2017
Osteoarthritis - Pipeline by TissueGene Inc, H1 2017
Osteoarthritis - Pipeline by Yooyoung Pharmaceutical Co Ltd, H1 2017
Osteoarthritis - Pipeline by Yuhan Corp, H1 2017
Osteoarthritis - Pipeline by Yungjin Pharm Co Ltd, H1 2017
Osteoarthritis - Pipeline by Zimmer Biomet Holdings Inc, H1 2017
Osteoarthritis - Dormant Projects, H1 2017
Osteoarthritis - Dormant Projects, H1 2017 (Contd..1), H1 2017
Osteoarthritis - Dormant Projects, H1 2017 (Contd..2), H1 2017
Osteoarthritis - Dormant Projects, H1 2017 (Contd..3), H1 2017
Osteoarthritis - Dormant Projects, H1 2017 (Contd..4), H1 2017
Osteoarthritis - Dormant Projects, H1 2017 (Contd..5), H1 2017
Osteoarthritis - Discontinued Products, H1 2017
Osteoarthritis - Discontinued Products, H1 2017 (Contd..1), H1 2017

Purchase Complete Report at http://www.reportsweb.com/buy&RW0001689443/buy/2000

Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com

ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support Vulvar Cancer is always available to help you on your research queries.

505, 6th floor, Amanora Township,
Amanora Chambers, East Block,
Kharadi Road, Hadapsar, Pune-411028

This release was published on openPR.